{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:56:57Z","timestamp":1790971017900,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T00:00:00Z","timestamp":1327449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0030840","type":"journal-article","created":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T16:58:21Z","timestamp":1327510701000},"page":"e30840","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer"],"prefix":"10.1371","volume":"7","author":[{"given":"Paul H.","family":"van der Horst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Vandenput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth C.","family":"K\u00fchne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred F. J.","family":"van IJcken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marten","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt W.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen J.","family":"Blok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.","volume":"127","author":"J Ferlay","year":"2010","journal-title":"International Journal of Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer.","volume":"366","author":"F Amant","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer Statistics, 2010.","volume":"60","author":"A Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/gyno.2002.6825","article-title":"Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?","volume":"87","author":"DE Cohn","year":"2002","journal-title":"Gynecologic Oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2006.01.038","article-title":"The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.","volume":"103","author":"S Jolly","year":"2006","journal-title":"Gynecologic Oncology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ssu.2980100107","article-title":"FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973\u201387 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.","volume":"10","author":"CL Kosary","year":"1994","journal-title":"Semin Surg Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2003.08.003","article-title":"Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?","volume":"91","author":"J Lindauer","year":"2003","journal-title":"Gynecologic Oncology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.","volume":"77","author":"CG Clemente","year":"1996","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1158\/0008-5472.CAN-09-4299","article-title":"An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer.","volume":"70","author":"PJ de Vos van Steenwijk","year":"2010","journal-title":"Cancer Research"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.","volume":"313","author":"J Galon","year":"2006","journal-title":"Science"},{"key":"ref11","first-page":"1","article-title":"Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology.","author":"N Hiraoka","year":"2010","journal-title":"International Journal of Clinical Oncology"},{"key":"ref12","article-title":"Density of Tumor-Infiltrating Lymphocytes Correlates with Disease Recurrence and Survival in Patients with Large Non-Small-Cell Lung Cancer Tumors.","author":"A Kilic","year":"2009","journal-title":"J Surg Res"},{"key":"ref13","first-page":"n\/a","article-title":"CD8+Foxp3+ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response.","author":"DT Le","year":"2010","journal-title":"International Journal of Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.bjc.6605820","article-title":"Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer.","volume":"103","author":"N Leffers","year":"2010","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer.","volume":"348","author":"L Zhang","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion.","volume":"67","author":"CE Clark","year":"2007","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2009.03.022","article-title":"Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.","volume":"114","author":"RA de Jong","year":"2009","journal-title":"Gynecologic Oncology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1158\/1078-0432.CCR-0732-3","article-title":"Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma.","volume":"10","author":"S Kondratiev","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0002-9378(88)90075-0","article-title":"Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.","volume":"158","author":"CE Ehrlich","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2005.08.001","article-title":"Steroid receptor expressions in endometrial cancer: Clinical significance and epidemiological implication.","volume":"239","author":"Y-T Jeon","year":"2006","journal-title":"Cancer Letters"},{"key":"ref21","first-page":"4190","article-title":"Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.","volume":"9","author":"EE Hanekamp","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2","article-title":"Progestin alone as primary treatment of endometrial carcinoma in premenopausal women.","volume":"79","author":"YB Kim","year":"1997","journal-title":"Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/humrep\/dei434","article-title":"Long-term conservative therapy for endometrial adenocarcinoma in young women.","volume":"21","author":"T Yahata","year":"2006","journal-title":"Hum Reprod"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.","volume":"17","author":"JT Thigpen","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-09-0814","article-title":"Progesterone inhibition of Wnt\/beta-catenin signaling in normal endometrium and endometrial cancer.","volume":"15","author":"Y Wang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1210\/en.2007-0756","article-title":"The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma.","volume":"149","author":"EC Ward","year":"2008","journal-title":"Endocrinology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/path.1402","article-title":"Nuclear \u03b2-catenin is a molecular feature of type I endometrial carcinoma.","volume":"201","author":"AN Scholten","year":"2003","journal-title":"The Journal of Pathology"},{"key":"ref28","article-title":"World Health Organisation: Tumours of the Breast and Female Genital Organs (Classification of Tumours)","author":"FA Tavassoli","year":"2003"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.","volume":"105","author":"S Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsgi.2005.01.003","article-title":"Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and\/or PRB-expressing endometrial cancer cell lines.","volume":"12","author":"E Smid-Koopman","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.","volume":"19","author":"BM Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response.","volume":"98","author":"VG Tusher","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0029-1242998","article-title":"Role of progesterone in endometrial cancer.","volume":"28","author":"JJ Kim","year":"2010","journal-title":"Semin Reprod Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/molehr\/gap100","article-title":"Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium.","volume":"16","author":"NM Mokhtar","year":"2010","journal-title":"Mol Hum Reprod"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1210\/jc.2002-020418","article-title":"Steroid and Cytokine Regulation of Matrix Metalloproteinase Expression in Endometriosis and the Establishment of Experimental Endometriosis in Nude Mice.","volume":"87","author":"KL Bruner-Tran","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7827-2-54","article-title":"Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase.","volume":"2","author":"CI Ace","year":"2004","journal-title":"Reprod Biol Endocrinol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-Mesenchymal Transitions in Development and Disease.","volume":"139","author":"JP Thiery","year":"2009","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2010.11.013","article-title":"Chemokines in cancer related inflammation.","author":"P Allavena","year":"2011"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/en.2005-1076","article-title":"Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women.","volume":"147","author":"S Talbi","year":"2006","journal-title":"Endocrinology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1023\/A:1025467500433","article-title":"The biology of antihormone failure in breast cancer.","volume":"80","author":"RI Nicholson","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0960-0760(00)00158-8","article-title":"The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer.","volume":"76","author":"DM Avila","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jsgi.2005.01.030","article-title":"Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins.","volume":"12","author":"EE Hanekamp","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0959-8049(02)00294-0","article-title":"Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancer.","volume":"38","author":"EE Hanekamp","year":"2002","journal-title":"Eur J Cancer"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1476-4598-9-162","article-title":"The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.","volume":"9","author":"DS Yee","year":"2010","journal-title":"Mol Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0344-0338(98)80129-5","article-title":"Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.","volume":"194","author":"T Brabletz","year":"1998","journal-title":"Pathol Res Pract"},{"key":"ref46","first-page":"2751","article-title":"Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin\/T-cell factor 4-mediated gene transactivation.","volume":"61","author":"Y Naishiro","year":"2001","journal-title":"Cancer Res"},{"key":"ref47","first-page":"280","article-title":"PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.","volume":"1","author":"C Hu","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canlet.2006.10.012","article-title":"Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.","volume":"250","author":"WK Ip","year":"2007","journal-title":"Cancer Lett"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1038\/sj.onc.1210362","article-title":"Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.","volume":"26","author":"X Jie","year":"2007","journal-title":"Oncogene"},{"key":"ref50","first-page":"1","article-title":"Identification of PEG10 and TSG101 as Carcinogenesis, Progression, and Poor-Prognosis Related Biomarkers for Gallbladder Adenocarcinoma.","author":"D-c Liu","year":"2011","journal-title":"Pathology & Oncology Research"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.4049\/jimmunol.179.5.2880","article-title":"CCL19 and CXCL13 synergistically regulate interaction between B cell acute lymphocytic leukemia CD23+CD5+ B Cells and CD8+ T cells.","volume":"179","author":"X Wang","year":"2007","journal-title":"J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.humrep.a138491","article-title":"Progesterone control of interleukin-8 production in endometrium and chorio-decidual cells underlines the role of the neutrophil in menstruation and parturition.","volume":"9","author":"RW Kelly","year":"1994","journal-title":"Hum Reprod"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1525-1438.2001.011001054.x","article-title":"Expression of interleukin-8 in human metastatic endometrial carcinoma cells and its regulation by inflammatory cytokines.","volume":"11","author":"KK Berry","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"ref54","first-page":"291","article-title":"The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene.","volume":"54","author":"PH Giangrande","year":"1999","journal-title":"Recent Prog Horm Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"32889","DOI":"10.1074\/jbc.272.52.32889","article-title":"Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor.","volume":"272","author":"PH Giangrande","year":"1997","journal-title":"J Biol Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1210\/mend.13.6.0300","article-title":"Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.","volume":"13","author":"MJ Tetel","year":"1999","journal-title":"Mol Endocrinol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1128\/MCB.20.9.3102-3115.2000","article-title":"The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.","volume":"20","author":"PH Giangrande","year":"2000","journal-title":"Mol Cell Biol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2174\/156652410791317039","article-title":"TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy.","volume":"10","author":"L Yang","year":"2010","journal-title":"Curr Mol Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-[beta] and immune cells: an important regulatory axis in the tumor microenvironment and progression.","volume":"31","author":"L Yang","year":"2010","journal-title":"Trends in Immunology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2199-11-64","article-title":"L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions.","volume":"11","author":"M Pfeifer","year":"2010","journal-title":"BMC Mol Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1083\/jcb.200408051","article-title":"L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.","volume":"168","author":"N Gavert","year":"2005","journal-title":"J Cell Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0030840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T19:00:53Z","timestamp":1561230053000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0030840"}},"subtitle":[],"editor":[{"given":"Irina","family":"Agoulnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,25]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0030840","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,25]]}}}